Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 96.76% | -46.70% | -56.32% | -95.97% | -2.47% |
| Total Depreciation and Amortization | 518.84% | 530.45% | 453.48% | 615.61% | -14.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -830.00% | 54.39% | -631.55% | 100.61% | 143.48% |
| Change in Net Operating Assets | -132.32% | 113.57% | 228.51% | -112.75% | 1,421.50% |
| Cash from Operations | -3.29% | 73.38% | 267.60% | -66.47% | 111.30% |
| Capital Expenditure | 100.00% | 66.67% | 95.14% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 66.67% | 95.14% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -51,893.10% | -171.43% | -94.44% | -265.52% | -38.10% |
| Issuance of Common Stock | -58.33% | -69.90% | -92.35% | -92.54% | -27.27% |
| Repurchase of Common Stock | -- | -- | 100.00% | 100.00% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -344,120.00% | 55.45% | 97.90% | 146,418.52% | 97.93% |
| Foreign Exchange rate Adjustments | 357.28% | 94.15% | -213.27% | 126.53% | -199.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -277.59% | 93.09% | 467.67% | -769.10% | 106.22% |